The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE
OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
CELATOR PHARMACEUTICALS INC COM 15089R102 7,301 2,246,469 SH   SOLE   2,246,469 0 0
HALLMARK FINL SVCS INC EC COM NEW 40624Q203 119 13,445 SH   SOLE   13,445 0 0
SYNTA PHARMACEUTICALS CORP COM 87162T206 150,057 28,641,849 SH   SOLE   28,641,849 0 0